Alvotech and Advanz Pharma Partner to Commercialize Biosimilar Eylea® Candidates in Europe

  Alvotech  a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz P...

June 18, 2024 | Tuesday | News
Adcytherix Launches with €30 Million Seed Funding to Pioneer Next-Generation Antibody-Drug Conjugates for Cancer Treatment

Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. Founded by the team that founded and sold Emergence T...

June 11, 2024 | Tuesday | News
Asensus Surgical to be Acquired by KARL STORZ in $300 Million Deal

Asensus Surgical, , a global leader of innovative digital solutions for the operating room, today announced that it has entered into a definitive merger ...

June 10, 2024 | Monday | News
BioNTech and CEPI Partner to Enhance mRNA Vaccine Production in Africa

BioNTech and CEPI aim to enhance local R&D, clinical and commercial-scale manufacturing capacities to develop potential mRNA vaccines in Africa, fo...

May 30, 2024 | Thursday | News
EU-Funded Project by Bio-Sourcing, Ciloa, and Intract Pharma Targets Inflammatory Diseases

  AB-BIOBETTER, led by Bio-Sourcing, to pioneer development of new oral formulation of adalimumab for inflammatory bowel diseases; offering patient...

May 28, 2024 | Tuesday | News
Helsinn Group and Angelini Pharma Renew Distribution Agreement for AULIN® and MESULID® in Eastern Europe

Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong ...

May 28, 2024 | Tuesday | News
Biogen Acquires Human Immunology Biosciences for $1.8 Billion to Bolster Pipeline in Immune-Mediated Diseases

Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-m...

May 23, 2024 | Thursday | News
Genmab Completes $1.8 Billion Acquisition of ProfoundBio, Secures Rights to Promising Cancer Treatments

Genmab has completed acquisition of ProfoundBio for USD 1.8 billion in cash Acquisition gives Genmab worldwide rights to three candidates in clini...

May 22, 2024 | Wednesday | News
YGION Biomedical Secures €15M in Series A Funding to Advance Personalized Cancer Vaccine Technology

YGION Biomedical GmbH, a company dedicated to developing individualized neoantigen-based cancer vaccines, today announced the completion of a Series A fina...

May 21, 2024 | Tuesday | News
Sanofi, Formation Bio, and OpenAI Forge Pioneering Partnership to Transform Drug Development with AI

Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to patients more eff...

May 21, 2024 | Tuesday | News
ARS Pharmaceuticals Advances neffy® MAA with CHMP Response, Inks CSL Seqirus Deal for Australia & New Zealand

CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by...

May 01, 2024 | Wednesday | News
Cidara Therapeutics Strikes $128 Million Deal to Divest rezafungin, Bolstering Focus on Cloudbreak Development

  Transaction provides company with an estimated approximately $128 million in cost savings, including approximately $67 million in clinical de...

April 25, 2024 | Thursday | News
Exergen Corporation Takes Legal Action to Protect Rights in Face of Baxter International's Censorship Attempt

Exergen Corporation, a leader in temperature measurement technology, has filed a lawsuit against Baxter International Inc. in the United States District Co...

April 24, 2024 | Wednesday | News
Bio-Rad to Invest in Oncocyte for Exclusive Global Transplant Monitoring Technology, Eyeing FDA Clearance and Market Expansion

Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-R...

April 12, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close